U.S. Specialized REITs Stock News

NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

C.H. Robinson Worldwide (CHRW) Posts Strong Q2 Results, Where Does Fair Value Sit?

C.H. Robinson Worldwide (CHRW) is back in focus after reporting higher second quarter revenue of US$4,934.1 million and net income of US$186.79 million, alongside affirming a regular quarterly dividend. See our latest analysis for C.H. Robinson Worldwide. The latest earnings and dividend news for C.H. Robinson Worldwide lands against a mixed price backdrop, with a 1-day share price return of 1.83% and a year-to-date share price return down 8.78%, while the 1-year total shareholder return of...
NasdaqGS:QBTS
NasdaqGS:QBTSSoftware

D Wave Quantum (QBTS) Stock Rallies On Bookings Surge Despite Heavy Losses

D-Wave Quantum came into this earnings print with a stock that had drifted over the past quarter, then jumped 7% in the first full session after results. That move reflects investors latching onto one headline metric. Bookings in the first half reached US$35.5 million, which sharply reset expectations around how quickly quantum systems and cloud access can convert into committed business. Beneath that, the story is less simple. Quarterly revenue was US$3.1 million and the company still...
NYSE:CAH
NYSE:CAHHealthcare

Is Cardinal Health (CAH) Undervalued On Strong Earnings Expectations?

Recent commentary on Cardinal Health (CAH) has focused on expectations for stronger quarterly earnings and revenue across core segments, along with value oriented ratings and fresh share price highs relative to sector peers. See our latest analysis for Cardinal Health. At a share price of US$236.40, Cardinal Health has given investors a 28.72% 90 day share price return and a 51.74% 1 year total shareholder return. This signals strong momentum despite a slight pullback in the latest session,...
NYSE:CL
NYSE:CLHousehold Products

How Investors Are Reacting To Colgate-Palmolive (CL) Reaffirming Guidance Amid Higher Sales And Lower Profit

In the second quarter of 2026, Colgate-Palmolive reported higher sales of US$5,361 million but lower net income of US$693 million compared with a year earlier, while first-half results showed a similar pattern of sales growth and reduced earnings. Despite this mix of rising revenue and softer profitability, the company maintained its full-year 2026 outlook for net sales growth of 2% to 6% and double-digit GAAP earnings per share growth, signaling confidence in its underlying plan. Next,...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

AdaptHealth (AHCO) Reports A Net Loss And Goodwill Impairment, Is The Stock A Bargain?

AdaptHealth earnings and impairment move into focus AdaptHealth (AHCO) is back on investors’ radar after second quarter 2026 results showed a net loss alongside a sizeable goodwill impairment, while management also updated full year revenue guidance. The company reported quarterly sales of US$740.31 million and a net loss of US$133.93 million, compared with net income a year earlier. It also recorded an unaudited goodwill impairment charge of US$144.24 million. Alongside these results,...